Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study

被引：0
|
作者：
C Hanotin
F Thomas
SP Jones
E Leutenegger
P Drouin
机构：
[1] Laboratoires Knoll France,Department of Clinical Research
[2] Knoll Pharmaceuticals,Department of Clinical Research
[3] Service de Diabétologie,undefined
[4] Maladies Métaboliques et Nutrition,undefined
[5] CHU de Nancy,undefined
[6] Hôpital Jeanne d'Arc,undefined
来源：
International Journal of Obesity | 1998年 / 22卷
关键词：
obesity; weight loss; sibutramine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
OBJECTIVES: To assess the weight-reducing effects and tolerability of 5 mg, 10 mg and 15 mg daily doses of sibutramine, a novel serotonin and noradrenaline reuptake inhibitor (SNRI).
引用
收藏
页码：32 / 38
页数：6
相关论文
共 50 条
  • [21] Dose-ranging studies
    Manion, D
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 8 - 9
  • [22] Dose-ranging study of an orlistat tablet formulation
    Schwartz, Susan M.
    Savastano, David M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (10) : 476 - 481
  • [23] A dose-ranging study of the behavioural effects of guarana
    Haskell, CF
    Kennedy, DO
    Milne, AL
    Wesnes, KA
    Scholey, AB
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A45 - A45
  • [24] Dose-ranging study of aripiprazole in patients with dementia of Alzheimer's disease
    Breder, C
    Swanink, R
    Marcus, R
    Kostic, D
    Iwamoto, T
    Carson, W
    McQuade, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S190 - S190
  • [25] A phase II dose-ranging study of mirabegron in patients with overactive bladder
    Christopher R. Chapple
    Vladimir Dvorak
    Pjotr Radziszewski
    Philip Van Kerrebroeck
    Jean Jacques Wyndaele
    Brigitte Bosman
    Peter Boerrigter
    Ted Drogendijk
    Arwin Ridder
    Ingrid Van Der Putten-Slob
    Osamu Yamaguchi
    International Urogynecology Journal, 2013, 24 : 1447 - 1458
  • [26] A DOSE-RANGING STUDY OF FLUTICASONE PROPIONATE IN ADULT PATIENTS WITH MODERATE ASTHMA
    DAHL, R
    LUNDBACK, B
    MALO, JL
    MAZZA, JA
    NIEMINEN, MM
    SAARELAINEN, P
    BARNACLE, H
    CHEST, 1993, 104 (05) : 1352 - 1358
  • [27] Effectiveness of fluticasone propionate in patients with moderate asthma: A dose-ranging study
    Wolfe, JD
    Selner, JC
    Mendelson, LM
    Hampel, F
    Schaberg, A
    CLINICAL THERAPEUTICS, 1996, 18 (04) : 635 - 646
  • [28] A confirmatory dose-ranging study of riluzole in ALS
    Lacomblez, L
    Bensimon, G
    Leigh, PN
    Guillet, P
    Powe, L
    Durrleman, S
    Delumeau, JC
    Meininger, V
    Puech, AJ
    Whitehead, J
    Asselain, B
    Cesaro, P
    Larrey, D
    Rossor, M
    Zimmerman, HJ
    Salzman, P
    Doppler, V
    Lloyd, CM
    Maloteaux, JM
    Delwaide, C
    Laterre, EC
    Bouchard, JP
    Duquette, P
    Girard, M
    Masse, C
    Eisen, A
    Blin, O
    Azulay, JP
    BilleTurc, F
    Pouget, J
    Bouche, P
    Camu, M
    Carlander, B
    Billiard, M
    Clanet, M
    Angibaud, G
    ArneBes, MC
    Benazet, M
    Couratier, P
    Vallat, JM
    Desnuelle, C
    Lagueny, A
    Ellie, E
    Dib, M
    Rozier, A
    Salachas, F
    Viader, F
    Delaunay, D
    Dengler, R
    Kuther, G
    NEUROLOGY, 1996, 47 (06) : S242 - S250
  • [29] A CHRONIC DOSE-RANGING STUDY OF THE PHARMACOKINETICS OF PHENYLBUTAZONE IN RHEUMATOID ARTHRITIC PATIENTS
    HIGHAM, C
    AARONS, L
    HOLT, PJL
    LYNCH, M
    ROWLAND, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (02) : 123 - 129
  • [30] A Dose-Ranging Study of Tolvaptan in Heart Failure Patients With Volume Overload
    Asanoi, Hidetsugu
    Matsuzaki, Masunori
    Hori, Masatsugu
    Izumi, Tohru
    Tsutamoto, Takayoshi
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S156 - S157
12345